posted
We are moving to .0052, get your bid in while you can, this one seems ready to fly. We are getting a good volume today. This is a steal at this price, way undervalue.
IP: Logged |
posted
Not sure where all this volume is coming from lately - only 3 or so people even bothered posting to this thread. I have a handful of shares, nothing major
others are involved and keeping quiet
i tend to find stocks that get surprise pr's - hoping this is one of them
IP: Logged |
posted
this has been dragged down and wound up since it hit a penny last time, they are going to have a hard time bringing down the PPO indicators any further imo, w/o letting it breathe. it may go sideways a little, but its due for a bounce imo, we'll see?? good chance for a penny if mm's let it go. dilution killed it to these levels, but as we have seen, they can still run hard, all these pigs are diluted, lol
never know with these pennies, i'll gamble with this one.. good luck
As for the chart, can't say if it looks like a bottom yet. There is positive divergence between the MACD and PPS since December 2006: http://tinyurl.com/2pdmtl
I assume the next thing the company will announce the 10K by the end of March. Looks like that is their filing schedule: http://tinyurl.com/2kz7yw
This could also be included: SAN CLEMENTE, Calif., Sept. 12, 2006 (PRIMEZONE) -- Preclinical testing has begun on the novel glaucoma treatment recently licensed by Advanced Refractive Technologies (OTC BB:ARFR.OB - News). This first step in clinical trials will assess the safety and efficacy of the compound before the initiation of human trials. The in vitro portion of this testing will require approximately six months to complete at which time the in vivo testing will begin. After six months of this in vivo testing, the Phase One human trials should be underway.
I think ARFR should heat up in February - I just like being early to the party
IP: Logged |
posted
search.. this news is actually a nice surprise, i was treating this as just a chart flip. but, i think your right, it may get some attention soon. nice DD. probably just another tale of MM's winding it up beyond belief shaking.. before....... BAM !!!! lol
As for the chart, can't say if it looks like a bottom yet. There is positive divergence between the MACD and PPS since December 2006: http://tinyurl.com/2pdmtl
I assume the next thing the company will announce the 10K by the end of March. Looks like that is their filing schedule: http://tinyurl.com/2kz7yw
This could also be included: SAN CLEMENTE, Calif., Sept. 12, 2006 (PRIMEZONE) -- Preclinical testing has begun on the novel glaucoma treatment recently licensed by Advanced Refractive Technologies (OTC BB:ARFR.OB - News). This first step in clinical trials will assess the safety and efficacy of the compound before the initiation of human trials. The in vitro portion of this testing will require approximately six months to complete at which time the in vivo testing will begin. After six months of this in vivo testing, the Phase One human trials should be underway.
I think ARFR should heat up in February - I just like being early to the party
Exellent post, getting in while this is so cheap. Thanks for your info.
IP: Logged |